𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymer Therapeutics Designed for a Combination Therapy of Hormone-Dependent Cancer

✍ Scribed by María J. Vicent; Francesca Greco; Robert I. Nicholson; Alison Paul; Peter C Griffiths; Ruth Duncan

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
439 KB
Volume
44
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymer Therapeutics Designed for a Comb
Polymer Therapeutics Designed for a Combination Therapy of Hormone-Dependent Cancer
✍ María J. Vicent; Francesca Greco; Robert I. Nicholson; Alison Paul; Peter C Grif 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Over the last decade, polymer therapeutics have emerged as first-generation nanomedicines. [1] The term polymer therapeutics was coined to include water-soluble polymers that are polymeric drugs, [2] hybrid polymer-drug [1, 3] and polymerprotein conjugates, [4] polymeric micelles that contain cova-

17β-hydroxysteroid dehydrogenase Type 1,
17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
✍ Joanna M. Day; Paul A. Foster; Helena J. Tutill; Michael F.C. Parsons; Simon P. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 551 KB

## Abstract Oestradiol (E2) stimulates the growth of hormone‐dependent breast cancer. 17β‐hydroxysteroid dehydrogenases (17β‐HSDs) catalyse the pre‐receptor activation/inactivation of hormones and other substrates. 17β‐HSD1 converts oestrone (E1) to active E2, but it has recently been suggested tha